Loracarbef – Oral products
Exceptions to the recognized standard of CLSI M100
No susceptibility test interpretive criteria are recognized at this time.
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.